Home
About Us
Help and Support
Subscribe
Company Analyst
Financial Analyst
Pipeline Analyst
Archives
Tools
Log In
Print this
ipragliflozin (ASP1941)
print preview
bookmark
share with colleague
General Information
Company
Astellas Pharma Inc.
Description
Sodium-glucose cotransporter 2 (SGLT2) inhibitor
Molecular Target
Sodium-glucose cotransporter 2 (SGLT2)
Mechanism of Action
Sodium-glucose cotransporter 2 (SGLT2) inhibitor
Latest Stage of Development
Registration
Indication
Diabetes
Partner
Kotobuki Pharmaceutical Co.
Product Summary: Number of Indications in each Phase of Development by Disease Category
More
Product Details
Archive Items are loading
Set Email Alert
dummy